Efficient Plasma Assay Enhances Early Alzheimer’s Detection
In the relentless pursuit of early detection methods for Alzheimer’s disease, a groundbreaking study has emerged, unveiling a resource-efficient, streamlined ...
Tag: Early Detection
Metabolomics Predicts Prostate Cancer Risk: Review Insights
The intricate role of metabolomic dysregulation in the pathogenesis of prostate cancer (PCa) has emerged as a focal point of ...
Evaluating Nevi Count: A Tool for Total Body Assessment
In recent years, skin cancer has become an increasing concern for numerous individuals across the globe. Among various risk factors ...
JNK3 Levels in Plasma Signal Parkinson’s Neuronal Damage
In an exciting development that could revolutionize the early diagnosis and monitoring of Parkinson’s disease, scientists have unveiled a groundbreaking ...
Emerging Biochemical Markers Enhance Ovarian Cancer Diagnosis
In a groundbreaking study that could revolutionize the way ovarian carcinoma is diagnosed and monitored, researchers have identified four novel ...
AI-Driven Ovarian Cancer Diagnosis: Spotlight on SOX17
In a groundbreaking study, researchers have unveiled an innovative diagnostic model for ovarian cancer that leverages the power of machine ...
AP3B1 and BMPR2: New Parkinson’s Blood Biomarkers
In a groundbreaking advancement poised to reshape Parkinson’s disease diagnostics, researchers have identified a synergistic blood-based biomarker duo, AP3B1 and ...
CA 15-3 and CEA Tumor Markers Used in the Diagnosis and Monitoring of Cancer
CA 15-3 is an epitope of the MUC1 glycoprotein. MUC1 is a transmembrane mucosa-associated glycoprotein and contains a large extracellular ...
